![[Image from Christopher Burns on Unsplash]](https://b2491169.smushcdn.com/2491169/wp-content/uploads/2020/11/christopher-burns-Kj2SaNHG-hg-unsplash-300x200.jpg?lossy=1&strip=1&webp=1)
In particular, natural language processing (NLP) could help health authorities transform adverse event reports from COVID-19 vaccines into structured data while reducing the need for manual data entry. But more importantly, the technique can accelerate adverse event detection while giving regulatory authorities the potential to predict and prevent future adverse events, according to Updesh Dosanjh, practice leader of technology solutions at IQVIA.
Get the whole story from our sister site, Drug Discovery & Development.